Colchicine 0.5 MG Oral Tablet

DRUG10 trials

Conditions

Acute GoutAmyotrophic Lateral SclerosisAnterior MIAtherosclerosis of ExtremitiesCOVID - 19Cardiovascular DiseasesChronic InflammationColchicine

Early Phase 1

Colchicine's Efficacy in MI Patients: Comparing PCI and Non-Reperfusion Approaches

CompletedNCT06426537

University of BrawijayaST-Elevation Myocardial Infarction

Start: 2022-10-20End: 2023-11-20Updated: 2024-05-24

Phase 1

EFFICACY OF COLCHICINE IN IMPROVING CLINICAL OUTCOMES IN PATIENTS WITH MILD TO MODERATE COVID-19 PNEUMONIA IN LAHORE: A RANDOMIZED CONTROL TRIAL

CompletedNCT06847204

Zaeema KanwalCOVID - 19

Start: 2025-02-24End: 2025-06-24Updated: 2025-09-04

Phase 2

Repurposing Colchicine for Reduction of Residual Inflammatory Risk in Type 1 Diabetes

Active, not recruitingNCT05949281

Asger Lund, MDCardiovascular Diseases, Chronic Inflammation, Type 1 Diabetes

Start: 2023-08-29End: 2031-01-15Updated: 2026-07-13

Colchicine Effect on Amyotrophic Lateral Sclerosis Patients

Not yet recruitingNCT07813858

Azienda Ospedaliero-Universitaria di ModenaAmyotrophic Lateral Sclerosis

Start: 2026-10-01End: 2028-12-01Target: 87Updated: 2026-09-10

Phase 3

Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk

RecruitingNCT04774159

Population Health Research InstituteAtherosclerosis of Extremities, Inflammation, Peripheral Arterial Disease

Start: 2021-05-06End: 2029-12-01Target: 6150Updated: 2026-03-24

Colchicine Protective Effect in Patients Undergoing Percutaneous Coronary Intervention (COLCHICINE-PROTECT)

NCT05739929

Helwan UniversityCoronary Artery Disease

Start: 2023-03-01End: 2024-08-30Target: 400Updated: 2023-03-22

Colchicine in Belgium in Patients With Coronary Artery Disease After Percutaneous Coronary Intervention

RecruitingNCT06095765

AZ Sint-Jan AVCoronary Artery Disease

Start: 2024-01-29End: 2028-03-01Target: 2770Updated: 2024-03-08

Design and Rationale of the COLT Study

Not yet recruitingNCT07432529

Azienda Sanitaria Locale ASL 6, LivornoPost-thrombotic Syndrome, Venous Insufficiency, Venous Thromboembolism (VTE) +1

Start: 2026-06-01End: 2027-06-01Target: 940Updated: 2026-02-25

Phase 4

Effect of Colchicine On Left Ventricle Function After Anterior Myocardial Infarction Assessed By Speckle Tracking

CompletedNCT05200052

Ain Shams UniversityAnterior MI, Colchicine

Start: 2022-02-01End: 2022-08-01Updated: 2022-08-23

Prednisolone Versus Colchicine for Acute Gout in Primary Care

TerminatedNCT05698680

University Medicine GreifswaldAcute Gout

Start: 2023-01-18End: 2026-02-28Updated: 2026-05-15

Related Papers

Efficacy of Colchicine in Reducing NT-proBNP, Caspase-1, TGF-β, and Galectin-3 Expression and Improving Echocardiography Parameters in Acute Myocardial Infarction: A Multi-Center, Randomized, Placebo-Controlled, Double-Blinded Clinical Trial

Journal of Clinical Medicine2025-02-182 citations

Low-dose colchicine for the prevention of cardiovascular events after percutaneous coronary intervention: Rationale and design of the COL BE PCI trial.

2024-09-021 citations

Prednisolone Versus Colchicine for Acute Gout in Primary Care: statistical analysis plan for the pragmatic, multicenter, randomized, and double-blinded COPAGO non-inferiority trial

Trials2024-04-03

Prednisolone Versus Colchicine for Acute Gout in Primary Care (COPAGO): protocol for a two-arm multicentre, pragmatic, prospective, randomized, double-blind, controlled clinical trial of prednisolone and colchicine for non-inferiority with a parallel group design.

2023-10-051 citations